KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CRISPR Therapeutics AG (CRSP) Profit After Tax (2016 - 2025)

Historic Profit After Tax for CRISPR Therapeutics AG (CRSP) over the last 11 years, with Q3 2025 value amounting to -$106.4 million.

  • CRISPR Therapeutics AG's Profit After Tax fell 2385.21% to -$106.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$488.3 million, marking a year-over-year decrease of 10380.18%. This contributed to the annual value of -$366.3 million for FY2024, which is 13842.98% down from last year.
  • Latest data reveals that CRISPR Therapeutics AG reported Profit After Tax of -$106.4 million as of Q3 2025, which was down 2385.21% from -$208.5 million recorded in Q2 2025.
  • CRISPR Therapeutics AG's Profit After Tax's 5-year high stood at $759.2 million during Q2 2021, with a 5-year trough of -$208.5 million in Q2 2025.
  • Over the past 5 years, CRISPR Therapeutics AG's median Profit After Tax value was -$113.2 million (recorded in 2021), while the average stood at -$65.4 million.
  • Per our database at Business Quant, CRISPR Therapeutics AG's Profit After Tax skyrocketed by 105312.97% in 2021 and then tumbled by 14175.97% in 2024.
  • Quarter analysis of 5 years shows CRISPR Therapeutics AG's Profit After Tax stood at -$141.2 million in 2021, then grew by 21.72% to -$110.6 million in 2022, then surged by 180.8% to $89.3 million in 2023, then crashed by 141.76% to -$37.3 million in 2024, then plummeted by 185.28% to -$106.4 million in 2025.
  • Its last three reported values are -$106.4 million in Q3 2025, -$208.5 million for Q2 2025, and -$136.0 million during Q1 2025.